 |
PDBsum entry 1idn
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Cell adhesion
|
PDB id
|
|
|
|
1idn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
6:923-935
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Cation binding to the integrin CD11b I domain and activation model assessment.
|
|
E.T.Baldwin,
R.W.Sarver,
G.L.Bryant,
K.A.Curry,
M.B.Fairbanks,
B.C.Finzel,
R.L.Garlick,
R.L.Heinrikson,
N.C.Horton,
L.L.Kelley,
A.M.Mildner,
J.B.Moon,
J.E.Mott,
V.T.Mutchler,
C.S.Tomich,
K.D.Watenpaugh,
V.H.Wiley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: The integrin family of cell-surface receptors mediate cell adhesion
through interactions with the extracellular matrix or other cell-surface
receptors. The alpha chain of some integrin heterodimers includes an inserted 'I
domain' of about 200 amino acids which binds divalent metal ions and is
essential for integrin function. Lee et al. proposed that the I domain of the
integrin CD11b adopts a unique 'active' conformation when bound to its counter
receptor. In addition, they proposed that the lack of adhesion in the presence
of Ca2+ ion reflected the stabilization of an 'inactive' I-domain conformation.
We set out to independently determine the structure of the CD11 b I domain and
to evaluate the structural effects of divalent ion binding to this protein.
RESULTS: We have determined the X-ray structure of a new crystal form of the
CD11 b I domain in the absence of added metal ions by multiple isomorphous
replacement (MIR). Metal ions were easily introduced into this crystal form
allowing the straight-forward assessment of the structural effects of divalent
cation binding at the metal ion dependent adhesion site (MIDAS). The equilibrium
binding constants for these ions were determined by titration calorimetry. The
overall protein conformation and metal-ion coordination of the I domain is the
same as that observed for all previously reported CD11 a I-domain structures and
a CD11 b I-domain complex with Mn2+. These structures define a majority
conformation. CONCLUSIONS: Addition of the cations Mg2+, Mn2+ and Cd2+ to the
metal-free I domain does not induce conformational changes in the crystalline
environment. Moreover, we find that Ca2+ binds poorly to the I domain which
serves to explain its failure to support adhesion. We show that the active
conformation proposed by Lee et al, is likely to be a construct artifact and we
propose that the currently available data do not support a dramatic structural
transition for the I domain during counter-receptor binding.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 1.
Figure 1. I domain secondary structure and conformational
comparison. (a) Ribbon diagram of the CD11b I domain with Mg2+
ion bound at the C-terminal end of the mostly parallel b sheet
(green). The seven a helices are shown in red. The Mg2+ ion
(pink sphere) is coordinated by the conserved residues Ser142,
Ser144 and Asp242, which are shown in ball-and-stick
representation. (b) Superimposed ribbon diagrams of the majority
conformation of the CD11b I domain (red) and the 1ido crystal
structure (green). The different positions of Phe275 and Phe302
(ball-and-stick representation) are indicated. The Mg2+ ions are
indicated by the pink and green spheres. (The figures were
prepared using MOLSCRIPT [82] and rendered using RASTER3D [83].)
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1998,
6,
923-935)
copyright 1998.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.L.Tang,
A.Vararattanavech,
and
S.M.Tan
(2008).
Urokinase-type plasminogen activator receptor induces conformational changes in the integrin alphaMbeta2 headpiece and reorientation of its transmembrane domains.
|
| |
J Biol Chem,
283,
25392-25403.
|
 |
|
|
|
|
 |
Y.Zhang,
H.N.Hayenga,
M.R.Sarantos,
S.I.Simon,
and
S.Neelamegham
(2008).
Differential regulation of neutrophil CD18 integrin function by di- and tri-valent cations: manganese vs. gadolinium.
|
| |
Ann Biomed Eng,
36,
647-660.
|
 |
|
|
|
|
 |
T.Vorup-Jensen,
L.Chi,
L.C.Gjelstrup,
U.B.Jensen,
C.A.Jewett,
C.Xie,
M.Shimaoka,
R.J.Linhardt,
and
T.A.Springer
(2007).
Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin.
|
| |
J Biol Chem,
282,
30869-30877.
|
 |
|
|
|
|
 |
T.Vorup-Jensen,
T.T.Waldron,
N.Astrof,
M.Shimaoka,
and
T.A.Springer
(2007).
The connection between metal ion affinity and ligand affinity in integrin I domains.
|
| |
Biochim Biophys Acta,
1774,
1148-1155.
|
 |
|
|
|
|
 |
A.J.Stein,
G.Fuchs,
C.Fu,
S.L.Wolin,
and
K.M.Reinisch
(2005).
Structural insights into RNA quality control: the Ro autoantigen binds misfolded RNAs via its central cavity.
|
| |
Cell,
121,
529-539.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.S.Rugg,
A.C.Willis,
D.Mukhopadhyay,
V.C.Hascall,
E.Fries,
C.Fülöp,
C.M.Milner,
and
A.J.Day
(2005).
Characterization of complexes formed between TSG-6 and inter-alpha-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan.
|
| |
J Biol Chem,
280,
25674-25686.
|
 |
|
|
|
|
 |
Y.Nymalm,
J.S.Puranen,
T.K.Nyholm,
J.Käpylä,
H.Kidron,
O.T.Pentikäinen,
T.T.Airenne,
J.Heino,
J.P.Slotte,
M.S.Johnson,
and
T.A.Salminen
(2004).
Jararhagin-derived RKKH peptides induce structural changes in alpha1I domain of human integrin alpha1beta1.
|
| |
J Biol Chem,
279,
7962-7970.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Vorup-Jensen,
C.Ostermeier,
M.Shimaoka,
U.Hommel,
and
T.A.Springer
(2003).
Structure and allosteric regulation of the alpha X beta 2 integrin I domain.
|
| |
Proc Natl Acad Sci U S A,
100,
1873-1878.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Whittaker,
and
R.O.Hynes
(2002).
Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.
|
| |
Mol Biol Cell,
13,
3369-3387.
|
 |
|
|
|
|
 |
J.L.Alonso,
M.Essafi,
J.P.Xiong,
T.Stehle,
and
M.A.Arnaout
(2002).
Does the integrin alphaA domain act as a ligand for its betaA domain?
|
| |
Curr Biol,
12,
R340-R342.
|
 |
|
|
|
|
 |
J.Takagi,
and
T.A.Springer
(2002).
Integrin activation and structural rearrangement.
|
| |
Immunol Rev,
186,
141-163.
|
 |
|
|
|
|
 |
M.A.Arnaout,
S.L.Goodman,
and
J.P.Xiong
(2002).
Coming to grips with integrin binding to ligands.
|
| |
Curr Opin Cell Biol,
14,
641-651.
|
 |
|
|
|
|
 |
M.Shimaoka,
J.Takagi,
and
T.A.Springer
(2002).
Conformational regulation of integrin structure and function.
|
| |
Annu Rev Biophys Biomol Struct,
31,
485-516.
|
 |
|
|
|
|
 |
J.Bella,
and
H.M.Berman
(2000).
Integrin-collagen complex: a metal-glutamate handshake.
|
| |
Structure,
8,
R121-R126.
|
 |
|
|
|
|
 |
J.R.Huth,
E.T.Olejniczak,
R.Mendoza,
H.Liang,
E.A.Harris,
M.L.Lupher,
A.E.Wilson,
S.W.Fesik,
and
D.E.Staunton
(2000).
NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding.
|
| |
Proc Natl Acad Sci U S A,
97,
5231-5236.
|
 |
|
|
|
|
 |
K.S.Taraszka,
J.M.Higgins,
K.Tan,
D.A.Mandelbrot,
J.H.Wang,
and
M.B.Brenner
(2000).
Molecular basis for leukocyte integrin alpha(E)beta(7) adhesion to epithelial (E)-cadherin.
|
| |
J Exp Med,
191,
1555-1567.
|
 |
|
|
|
|
 |
C.Oxvig,
C.Lu,
and
T.A.Springer
(1999).
Conformational changes in tertiary structure near the ligand binding site of an integrin I domain.
|
| |
Proc Natl Acad Sci U S A,
96,
2215-2220.
|
 |
|
|
|
|
 |
O.Pentikäinen,
A.M.Hoffrén,
J.Ivaska,
J.Käpylä,
T.Nyrönen,
J.Heino,
and
M.S.Johnson
(1999).
"RKKH" peptides from the snake venom metalloproteinase of Bothrops jararaca bind near the metal ion-dependent adhesion site of the human integrin alpha(2) I-domain.
|
| |
J Biol Chem,
274,
31493-31505.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.J.Gotwals,
G.Chi-Rosso,
S.T.Ryan,
I.Sizing,
M.Zafari,
C.Benjamin,
J.Singh,
S.Y.Venyaminov,
R.B.Pepinsky,
and
V.Koteliansky
(1999).
Divalent cations stabilize the alpha 1 beta 1 integrin I domain.
|
| |
Biochemistry,
38,
8280-8288.
|
 |
|
|
|
|
 |
Q.Chen,
Y.Zhang,
D.M.Johnson,
and
P.F.Goetinck
(1999).
Assembly of a novel cartilage matrix protein filamentous network: molecular basis of differential requirement of von Willebrand factor A domains.
|
| |
Mol Biol Cell,
10,
2149-2162.
|
 |
|
|
|
|
 |
T.A.Salminen,
Y.Nymalm,
J.Kankare,
J.Käpylä,
J.Heino,
and
M.S.Johnson
(1999).
Production, crystallization and preliminary X-ray analysis of the human integrin alpha1 I domain.
|
| |
Acta Crystallogr D Biol Crystallogr,
55,
1365-1367.
|
 |
|
|
|
|
 |
R.Li,
P.Rieu,
D.L.Griffith,
D.Scott,
and
M.A.Arnaout
(1998).
Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures.
|
| |
J Cell Biol,
143,
1523-1534.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |